| Name | CQ211 |
|---|
| Description | CQ211 is a potent and selective RIOK2 inhibitor with a Kd of 6.1 nM. CQ211 exhibits potent proliferation inhibition activity against multiple cancer cell lines[1]. |
|---|---|
| Related Catalog | |
| Target |
Kd: 6.1 nM (RIOK2)[1] |
| In Vivo | CQ211 (25 mg/kg) inhibits the tumor progression with tumor growth inhibition (TGI) of 30.9% in rats[1]. |
| References |
| Molecular Formula | C26H22F3N7O2 |
|---|---|
| Molecular Weight | 521.49 |